Assessment of the lymphocyte repertoire in relapsing-remitting multiple sclerosis patients treated with ocrelizumab: the ImmunoReMS study

被引：0
|
作者：
Esposito, Federica [1 ,2 ]
Ferre, Laura [1 ,2 ]
Mascia, Elisabetta [2 ]
Sorosina, Melissa [2 ]
Clarelli, Ferdinando [2 ]
Santoro, Silvia [2 ]
Giordano, Antonino [1 ,2 ]
Cannizzaro, Miryam [1 ,2 ]
Moiola, Lucia [1 ]
Martinelli, Vittorio [1 ]
Filippi, Massimo [3 ,4 ,5 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Neurol Unit, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Div Neurosci, Lab Human Genet Neurol Disorders, INSPE, Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Neurol & Neurorehabil Unit, Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit, INSPE, Milan, Italy
[5] Univ Vita Salute San Raffaele, Milan, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1285/1895
引用
收藏
页码：815 / 815
页数：1
相关论文
共 50 条
  • [31] Fatigue in Treated and Untreated Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Yaldizli, Oe
    Katsarava, Z.
    Vago, S.
    Limmroth, V.
    Putzki, N.
    AKTUELLE NEUROLOGIE, 2008, 35 (09) : 425 - 429
  • [32] Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis
    Roos, Izanne
    Sharmin, Sifat
    Malpas, Charles
    Ozakbas, Serkan
    Lechner-Scott, Jeannette
    Hodgkinson, Suzanne
    Alroughani, Raed
    Izquierdo, Guillermo
    Eichau Madueno, Sara
    Boz, Cavit
    van der Walt, Anneke
    Butzkueven, Helmut
    Buzzard, Katherine
    Skibina, Olga
    Foschi, Matteo
    Grand'Maison, Francois
    John, Nevin
    Grammond, Pierre
    Terzi, Murat
    Prevost, Julie
    Barnett, Michael
    Laureys, Guy
    Van Hijfte, Liesbeth
    Luis Sanchez, Jose
    Blanco, Yolanda
    Oh, Jiwon
    Mccombe, Pamela
    Ramo Tello, Cristina
    Soysal, Aysun
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Yamout, Bassem I.
    Khoury, Samia
    Van Pesch, Vincent
    Macdonell, Richard
    Sa, Maria Jose
    Slee, Mark
    Kuhle, Jens
    Maimone, Davide
    Spitaleri, Daniele L. A.
    Willekens, Barbara
    Al-Asmi, Abdullah
    Robertson, Neil
    Coles, Alasdair
    Brown, J. William L.
    Kalincik, Tomas
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 629 - 631
  • [33] IL-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone
    Losy, J.
    Szczucinski, A.
    MULTIPLE SCLEROSIS, 2007, 13 : S37 - S37
  • [34] Real-world persistence, adherence and treatment satisfaction in patients with relapsing-remitting multiple sclerosis treated with ocrelizumab for 2 years
    Trojano, Maria
    van Pesch, Vincent
    Alroughani, Raed
    Rovira Canellas, Alex
    Cutter, Gary
    Dzhenkova, Dima
    Hagenbuch, Niels
    Siadimas, Thanos
    Camerlingo, Sebastian
    Craveiro, Licinio
    Hobart, Jeremy
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1084 - 1085
  • [35] Cognitive impairment in patients with relapsing-remitting multiple sclerosis
    Mendes, M. F.
    Balsimelli, S.
    Tilbery, C. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S142 - S142
  • [36] Cardiovascular abnormalities in patients with relapsing-remitting multiple sclerosis
    El-Ghoneimy, Lobna Ahmed Talaat
    Shalaby, Nevin
    Elmazny, Alaa
    El-Baghdady, Yasser
    Shehata, Hatem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP3 - NP3
  • [37] Cognitive impairment in relapsing-remitting multiple sclerosis patients
    Altinkaya, A.
    Ozcan, E.
    Yandim-Kuscu, D.
    Kurt, E.
    Bingol, A.
    Kirbas, D.
    Topcular, B.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 406 - 406
  • [38] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [39] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [40] Planned dose reduction of ocrelizumab in relapsing-remitting multiple sclerosis: a single-centre observational study
    Tran, Trung Dang Quoc
    Hall, Leanne
    Heal, Clare
    Haleagrahara, Nagaraja
    Edwards, Sharon
    Boggild, Mike
    BMJ NEUROLOGY OPEN, 2024, 6 (01)
12345